Navigation Links
Marken Announces Global Advisory Board
Date:6/21/2012

RESEARCH TRIANGLE PARK, N.C., June 21, 2012 /PRNewswire/ -- Marken announced today the first Marken Global Advisory Board, held on June 19, 2012. As the leader in global life science supply chain management, Marken continues to be the forerunner for promoting industry trends and innovation as well as establishing international best practices.  This strategic and technical board of global advisors was hand-picked to provide Marken clients evolving industry knowledge and perspectives for regulatory, temperature sensitive, clinical specimen aspects of the end to end Pharmaceutical Supply Chain.  The internationally recognized experience of the advisory board positions Marken to provide consulting and leadership to its clients globally and will represent Marken as opinion leaders.

(Logo: http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

Advisory Board Members:

Rafik H. Bishara, PhD is the current Chair of the Pharmaceutical Cold Chain Interest Group (PCCIG) within the Parenteral Drug Association PDA) formerly Director, Quality Knowledge Management and Technical Support with Eli Lilly & Co. for 35+ years.

Laurent Foetisch is Founder and Managing Director of Supply Chain Operations SA, formerly Vice President of Global Supply Chain for Merck Serono and Serono for over 20 years.

Alan Horgan is an independent consultant working with Whiteacres Associates LLC and formerly Group Vice President, Late Stage Development MDS Pharma Services and Corporate Senior Vice President & Global President of Clinical Development for Covance.

Hedley Rees is Managing Consultant, Biotech PharmaFlow expert in Lean Thinking and Production Systems.  Hedley is a strong advocate of the regulatory modernization frameworks of FDA's 21st Century Modernization and ICH Q8 – Q11.

"The drive, passion and energy of this new Global Advisory Board will not only propel Marken to new levels, but will also ensure higher standards of patient care by forging new industry expectations for supply chain service.  It's exciting to be setting this stage for not only our current markets, but in areas of the world that need this type of leadership to better serve their investigator sites and ultimately, the patient." said Wes Wheeler, CEO. 

About Marken

Marken is the leading global clinical supply chain solutions provider dedicated 100% to the pharmaceutical and life sciences industries, supporting over 49,000 investigator sites in more than 150 countries. Our team members and network of facilities bridge the distance between patients and the essential resources of life science companies.


'/>"/>
SOURCE Marken
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Opens Branch Office In Seoul, South Korea
2. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
3. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
4. Generex Announces Results of Annual Stockholders Meeting
5. SCOLR Pharma Announces Unaudited Net Sales of Nutritional Products
6. Scioderm Announces Positive Phase II Data of Topical SD-101 on Wound Closure and Reduction of Lesions and Blisters in Children with Epidermolysis Bullosa (EB)
7. Canada-based Radimetrics Announces Expansion to Scotland
8. Aethlon Medical Announces Notice of Allowance of U.S. Patent Application Covering a Medical Device to Remove Microvesicular Particles, Including Exosomes
9. American Oriental Bioengineering Announces Appointment of Audit Committee Chairman
10. Dehaier Medical Announces Strategic Mutual Cooperation Agreement with HEYER Medical AG
11. Concord Medical Announces its Successful Closing of the Acquisition of 52% Ownership in Changan Hospital and Provides Guidance for Financial Results of the Second Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ZIONA SCIENCE PARK , Israel ... company Kadimastem (TASE: KDST) announced today the signing of a memorandum ... between the companies. The synergy between the companies will assist in ... as a worldwide leader in innovative treatment for severe diseases in ... ...
(Date:12/7/2016)... 7, 2016  Organovo Holdings, Inc. (NASDAQ: ... focused on delivering scientific and medical breakthroughs using ... and Chief Executive Officer Keith Murphy ... December 14, 2016 at 1:00 p.m. Eastern Time ... yet familiar with the Company, an informational video ...
(Date:12/7/2016)... The global  blood screening ... USD 3.9 billion by 2024, based on a ... growth of the market is attributed to the ... by the market players. Demand for blood screening ... rising awareness about transfusion-transmitted diseases, and technological developments ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... , ... AlignLife clinics nationwide are giving back to their communities by collecting ... bountiful gifts wrapped tightly under a Christmas Tree. AlignLife hopes to spread the ... , In exchange for generous donations, customers will receive a gift in return. ...
(Date:12/7/2016)... ... 2016 (PRWEB) (PRWEB) December 07, 2016 , ... Man’s best ... Dermatitis Associated with Borrelia Infection” reveals that a condition similar to ... prestigious Journal of Veterinary Science & Medical Diagnosis. , Morgellons disease is an ...
(Date:12/7/2016)... ... December 07, 2016 , ... The Honolulu cosmetic ... redesigned website, which launched October 17, 2016, features comprehensive information regarding a wide ... layout. Visitors and patients can discover the latest clinical dermatology treatments for medical ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and Laser ... Holiday Party Season. Save Up To 33% Off Botox® and Juvederm® Products Now Through ... Phoenix Valley with Delightful Deals on Botox® and Juvederm® just in time ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... Campaign Winner in the Folio: Marketing Awards competition. Live From won in the ... in pioneering, inventive, and ultimately successful projects undertaken by the media industry’s most ...
Breaking Medicine News(10 mins):